TY  - GEN
AU  - Volf,Eva M
AU  - Au,Shiu-Chung
AU  - Dumont,Nicole
AU  - Scheinman,Pamela
AU  - Gottlieb,Alice B
TI  - A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis
SN  - 1545-9616
PY  - 2012///0628
KW  - Adult
KW  - Aged
KW  - Dermatitis, Allergic Contact
KW  - drug therapy
KW  - Dermatitis, Atopic
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Phosphodiesterase 4 Inhibitors
KW  - administration & dosage
KW  - Severity of Illness Index
KW  - Thalidomide
KW  - adverse effects
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
ER  -